Literature DB >> 6720266

Retinal vein occlusion: C-reactive protein and arterial hypertension.

P M Dodson, B Shine.   

Abstract

Eighty-six patients with retinal vein occlusion (37 with central, 49 with branch vein occlusion) and 31 patients with treated essential arterial hypertension were investigated for comparison to an age-matched control group. Serum C-reactive protein (CRP) levels, erythrocyte sedimentation rate (ESR) and plasma viscosity were measured. Serum CRP levels (log10 values) were significantly elevated in patients, with hypertension (P less than 0.001) or with retinal vein occlusion (P less than 0.001) compared to control. The highest mean value of serum CRP were found in patients with both hypertension and retinal vein occlusion, and the values of ESR and serum CRP were significantly higher in this group when compared to normotensive patients with retinal vein occlusion (P less than 0.05 and P less than 0.01, respectively) or to control (P less than 0.001). Increased inflammatory activity may be present in patients with hypertension or retinal vein occlusion. In particular hypertensive patients with elevated serum CRP levels may be more at risk of developing retinal vein occlusion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6720266     DOI: 10.1111/j.1755-3768.1984.tb06765.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  8 in total

Review 1.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Cyclic variation in onset of central retinal vein occlusion.

Authors:  M J Lavin; B J Dhillon
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

Review 3.  Management of retinal vein occlusion.

Authors:  P M Dodson; E E Kritzinger
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-05

Review 4.  Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.

Authors:  Matthias Hermann; Frank Enseleit; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

5.  Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.

Authors:  M D Cole; P M Dodson; S Hendeles
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

6.  Evaluation of Systemic Endothelial Dysfunction in Retinal Vein Occlusions.

Authors:  Erdinc Bozkurt; Turkhun Cetin; Ibrahim Rencuzogullari
Journal:  Beyoglu Eye J       Date:  2022-05-27

7.  Medical conditions underlying recurrence of retinal vein occlusion.

Authors:  P M Dodson; A J Kubicki; K G Taylor; E E Kritzinger
Journal:  Br J Ophthalmol       Date:  1985-07       Impact factor: 4.638

Review 8.  Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.

Authors:  Chen Liu; Rodney E Kellems; Yang Xia
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.